OPR - Delayed Quote • USD PLX May 2024 2.000 put (PLX240517P00002000) Follow 0.8500 +0.0500 (+6.25%) As of April 26 at 2:38 PM EDT. Market Open. Comparisons Indicators Technicals Corporate Events Chart Types Aggregated Types Draw Table View List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Date Close Open High Low Volume O H L C Vol AAPL Loading Chart for PLX240517P00002000 1D 5D 1M 3M 6M YTD 1Y 2Y 5Y All Date Range 1 min 1 min 2 mins 3 mins 5 mins 15 mins 30 mins 1 hour 4 hours Recent News: PLX Protalix BioTherapeutics, Inc. (AMEX:PLX) Q4 2023 Earnings Call Transcript PLX: Elfabrio Geographic Expansion Protalix BioTherapeutics Inc Reports Revenue Growth and Net Income Gain in FY 2023 Protalix BioTherapeutics Reports Fiscal Year 2023 Financial and Business Results Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024 Protalix BioTherapeutics to Participate in the 2024 BIO CEO & Investor Conference Protalix BioTherapeutics Issues 2024 Letter to Stockholders Levicept Appoints Eliot Forster as CEO Protalix BioTherapeutics, Inc. (AMEX:PLX) Q3 2023 Earnings Call Transcript PLX: More Regulatory Approvals Protalix BioTherapeutics Inc (PLX) Reports Q3 2023 Financial Results Protalix BioTherapeutics Reports Third Quarter 2023 Financial and Business Results
